Qube Research & Technologies LTD Eli Lilly & CO Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 213,835 shares of LLY stock, worth $170 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

213,835

Previous 329,557 35.11%

Holding current value

$170 Million

Previous $298 Million 36.51%

% of portfolio

0.29%

Previous 0.48%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $89.4 Million - $111 Million	-115,722 Reduced 35.11%	213,835 $189 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $114 Million - $143 Million	157,288 Added 91.3%	329,557 $298 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $111 Million - $149 Million	-187,660 Reduced 52.14%	172,269 $134 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $29.2 Million - $34.4 Million	-55,544 Reduced 13.37%	359,929 $210 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $181 Million - $249 Million	415,473 New	415,473 $223 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $8.03 Million - $9.15 Million	27,095 Added 78.28%	61,710 $20 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $31.8 Million - $37.4 Million	-114,161 Reduced 76.73%	34,615 $11.2 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $34.9 Million - $43.4 Million	148,776 New	148,776 $42.6 Million
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $21.1 Million - $26.2 Million	-93,983 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $5.19 Million - $6.39 Million	23,435 Added 33.22%	93,983 $21.7 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $798,933 - $1.03 Million	-4,425 Reduced 5.9%	70,548 $16.2 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $2.86 Million - $3.7 Million	17,408 Added 30.24%	74,973 $14 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $10.5 Million - $13.9 Million	-80,797 Reduced 58.4%	57,565 $9.72 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $15.9 Million - $18.4 Million	108,511 Added 363.51%	138,362 $20.5 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $3.85 Million - $4.64 Million	28,248 Added 1762.2%	29,851 $4.9 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $190,837 - $236,202	1,603 New	1,603 $222,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $388,012 - $480,588	-3,629 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $987,487 - $1.07 Million	-9,247 Reduced 71.82%	3,629 $406,000
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $3.65 Million - $4.26 Million	-32,950 Reduced 71.9%	12,876 $1.43 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $4.79 Million - $5.63 Million	43,004 Added 1523.88%	45,826 $5.95 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.1 Million - $1.23 Million	-10,357 Reduced 78.59%	2,822 $327,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.1 Million - $1.38 Million	12,814 Added 3510.68%	13,179 $1.41 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $52,535 - $60,294	-694 Reduced 65.53%	365 $31,000
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $78,588 - $92,768	1,059 New	1,059 $81,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Eli Lilly & CO Transaction History